Washington Post: Bisphosphonates among Drugs Doctors “Recommend When They Shouldn’t”
Previous posts have discussed the link between bisphosphonates and atypical fractures.
Less than a week after the Wall Street Journal published an article discussing a new study that found the bisphosphonates can increase the risk of atypical fractures, the Washington Post published an article describing the most typical drugs and procedures that are recommended by doctors which go against the practices that would be recommended based on current medical research. The article mentions that doctors commonly prescribe bisphosphonates such as Fosamax or Boniva for osteopenia although “there is little evidence that people with osteopenia benefit from the drugs.”
Not only do the drugs do little to help people with osteopenia but such prescriptions, according to the Washington Post, “pose numerous risks that include thigh fractures, throat or chest pain, and difficulty swallowing.”
Thompson and Tredennick partner Ted Tredennick comments, “The continuing media attention to the risk of bisphosphonates further highlights the dangers that continued use of bisphosphonates cause.”
Nick Bruno is a Legal Assistant at Thompson & Tredennick
